These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1575153)

  • 1. Adult respiratory distress syndrome following thrombolytic therapy with APSAC for acute myocardial infarction.
    Le SP; Chatterjee K; Wolfe CL
    Am Heart J; 1992 May; 123(5):1368-9. PubMed ID: 1575153
    [No Abstract]   [Full Text] [Related]  

  • 2. [The adult respiratory distress syndrome as a complication of the APSAC treatment of acute myocardial infarct. Apropos a case].
    García González MJ; Bosa Ojeda F; Barragán Acea A; Marrero Rodríguez F; Laynez Cerdeña I; Lara Padrón A; Lacalzada Almeida J; de Armas Trujillo D
    Rev Esp Cardiol; 1993 Oct; 46(10):674-6. PubMed ID: 8235004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome after acute myocardial infarction treated with anistreplase.
    Ancillo P; Duarte J; Cortina JJ; Sempere AP; Clavería LE
    Chest; 1994 Apr; 105(4):1301-2. PubMed ID: 8162787
    [No Abstract]   [Full Text] [Related]  

  • 4. Rash after treatment with anistreplase.
    Burrows N; Jones RR
    Br Heart J; 1990 Oct; 64(4):289-90. PubMed ID: 2223309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypersensitivity vasculitis after thrombolytic therapy with APSAC (anisoylated plasminogen streptokinase activator complex). Presentation of a clinical case and review of the literature].
    Gianni R; Benucci M; Santoro E; Nenci G; Baruffi MC; Cappelletti C
    Ann Ital Med Int; 1994; 9(2):105-6. PubMed ID: 7917762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cholesterol crystal embolization after intravenous thrombolysis by anistreplase for suspected myocardial infarction].
    Coppere B; Granade G; Girard-Madoux MH; Claudel JP; Kruszynski G; Porte J; Gayral M; Ninet J
    Presse Med; 1992 Dec; 21(42):2061. PubMed ID: 1294983
    [No Abstract]   [Full Text] [Related]  

  • 7. Domiciliary thrombolytic treatment.
    BMJ; 1991 Aug; 303(6799):417-8. PubMed ID: 1912821
    [No Abstract]   [Full Text] [Related]  

  • 8. A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex, APSAC) in acute myocardial infarction.
    Brügemann J; van der Meer J; Takens BH; Hillege H; Lie KI
    Br Heart J; 1990 Dec; 64(6):355-8. PubMed ID: 2271340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemorrhagic aspects of thrombolytic therapy.
    Samama M
    Eur Heart J; 1990 Aug; 11 Suppl F():15-8. PubMed ID: 2121488
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
    Shammas NW; Zeitler R; Fitzpatrick P
    Clin Cardiol; 1993 Apr; 16(4):283-92. PubMed ID: 8458108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the practicality and safety of thrombolysis with anistreplase given by general practitioners.
    Hannaford P; Vincent R; Ferry S; Hirsch S; Kay C
    Br J Gen Pract; 1995 Apr; 45(393):175-9. PubMed ID: 7612317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of thrombolytic therapy with the preparation APSAC on the course of myocardial infarct].
    Urazgil'deeva SA; Aminieva KhK; Varshavskiĭ SIu
    Ter Arkh; 1994; 66(9):41-5. PubMed ID: 7992211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term comparative study of anistreplase versus streptokinase in acute myocardial infarction.
    Silber H; Hausmann MJ; Katz A; Gilutz H; Zucker N; Ovsyshcher I
    Angiology; 1992 Jul; 43(7):572-7. PubMed ID: 1626735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic therapy for coronary occlusion.
    Thompson PL
    Med J Aust; 1992 Jul; 157(2):75-7. PubMed ID: 1630392
    [No Abstract]   [Full Text] [Related]  

  • 15. Oesophageal dissection after thrombolytic treatment for myocardial infarction.
    Jishi F; Sissons CE; Silverstone EJ; Coakley JF; Fraser F
    Thorax; 1992 Oct; 47(10):835-6. PubMed ID: 1481188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic thrombolysis with APSAC in a young adult with healthy coronary vessels].
    Mongiat C; Sforza G; Marchese D
    Minerva Anestesiol; 1991 Dec; 57(12):1656. PubMed ID: 1795804
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind randomised dose-effect trial of anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction. The APSAC Research Group.
    Clin Trials Metaanal; 1993 Nov; 28(6):317-28. PubMed ID: 10150180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ST-segment analysis: a useful marker for reperfusion after thrombolysis with APSAC? The Belgian EMS Study Group.
    Bossaert L; Conraads V; Pintens H
    Eur Heart J; 1991 Mar; 12(3):357-62. PubMed ID: 2040318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of new thrombolytic agents in myocardial infarction: a multicenter randomized trial (APSAC versus rt-PA)].
    Cassagnes J; Machecourt J; Bassand JP; Lusson JR; Wolf JE; Anguenot T; Maublant J; Fagret D; Cardot JC
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1593-9. PubMed ID: 1300957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolysis with intravenous APSAC in patients with acute myocardial infarction].
    Ribeiro E; Silva LA; Petrizzo A; Torossian SP; Oliveira JL; Buffollo E; Duprat Filho R
    Arq Bras Cardiol; 1991 Jul; 57(1):5-8. PubMed ID: 1823762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.